Delivery Order SPE2DE24DA017-SPE2D625F1RVN
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,577.20 on August 18, 2025, for the supply of ARTHREX ANGEL PRP Kits (US Tray). The contract, which utilizes fixed-price pricing with economic price adjustment terms, is scheduled for completion by August 21, 2025, and will be performed at Arthrex's Naples, Florida location. The award carries no set-aside designation, reflecting the company's strong...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,430.88 on July 23, 2025, for the supply of ARTHREX ANGEL PRP Kit (US Tray). This fixed-price delivery order with economic price adjustment is scheduled for completion by July 28, 2025, and will be performed at Arthrex's Naples, FL facility. The award was issued through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a fixed-price delivery order valued at $35,772 from the Defense Logistics Agency's Medical Supply Chain on August 14, 2025, for the ARTHREX ANGEL PRP Kit (US Tray). The contract, which carries an ultimate completion date of August 19, 2025, was awarded without a set-aside designation, reflecting Arthrex's competitive strength in the federal orthopedic medical device marketplace. The...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,577.20 for the ARTHREX ANGEL PRP Kit (US Tray) by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, with an ultimate completion date of August 18, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, reflecting Arthrex's competitive standing in the federal marketplace. The delivery...
- Arthrex Inc. has been awarded a delivery order valued at $2,861.76 for the ARTHREX ANGEL PRP Kit (US Tray) under a fixed-price contract with economic price adjustment provisions. The award was issued on August 19, 2025, with an ultimate completion date of August 22, 2025. This delivery order was placed through the Defense Logistics Agency's Medical Supply Chain, which serves the Department of Defense and Veterans Administration healthcare systems. The contract carries no set-aside designation,...
- Arthrex Inc. has been awarded a delivery order valued at $17,287.60 for the ARTHREX ANGEL PRP Kit (US Tray) under a fixed-price contract with economic price adjustment provisions. The award, issued on August 12, 2025, with an ultimate completion date of August 15, 2025, supports the Defense Logistics Agency's Medical Supply Chain operations. The contract contains no small business set-aside designation, reflecting Arthrex's established competitive position in the federal orthopedic medical...
- Arthrex Inc. was awarded a delivery order valued at $2,861.76 for the ARTHREX ANGEL PRP Kit (US Tray) on August 8, 2025, with an ultimate completion date of August 13, 2025. This fixed-price contract with economic price adjustment is being funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for supplying medical equipment to government healthcare systems. The delivery order represents a standard, non-set-aside competitive award to the...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $12,520.20 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 7, 2025, for the ARTHREX ANGEL PRP Kit. The delivery order, which carries an ultimate completion date of August 12, 2025, was awarded without set-aside designation, reflecting Arthrex's competitive strength in the federal orthopedic medical device marketplace. This order represents a...
- Arthrex Inc., a leading developer and manufacturer of minimally invasive orthopedic medical technologies based in Naples, Florida, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, for the supply of ARTHREX ANGEL PRP Kits. The contract, valued at $3,577.20, is structured as a fixed-price delivery order with economic price adjustment provisions and has an ultimate completion date of July 30, 2025. This award was made without a set-aside...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $7,154.40 on August 4, 2025, for the Arthrex ANGEL PRP Kit (US Tray). This fixed-price delivery order with economic price adjustment is set to be completed by August 7, 2025, and will be performed at the company's Naples, Florida facility. The award was issued through the Defense Logistics Agency's Medical Supply Chain, a defense agency component...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F1RVNDelivery Order
Arthrex Inc. has been awarded a delivery order valued at $1,073.16 for the supply of ARTHREX ANGEL PRP Kit (US Tray) with an ultimate completion date of August 27, 2025. This fixed-price contract with economic price adjustment was issued on August 22, 2025, by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for providing medical supplies to the Department of Defense and Veterans Affairs. The delivery is to be performed in Naples, Florida, where Arthrex maintains its headquarters. No set-aside designation was applied to this award, reflecting Arthrex's competitive position in the federal medical device marketplace. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and running through September 1, 2029. The ANGEL PRP Kit is a specialized orthopedic biological product used in minimally invasive procedures, consistent with Arthrex's core business of supplying innovative orthopedic medical technologies, surgical implants, and instruments to government healthcare systems. The parent IDC enables VA medical centers and military healthcare facilities nationwide to efficiently access Arthrex's comprehensive orthopedic solutions portfolio to support the specialized surgical and medical needs of veterans and active-duty military personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/22/25 |